{"id":701830,"date":"2022-10-27T08:21:26","date_gmt":"2022-10-27T12:21:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/"},"modified":"2022-10-27T08:21:26","modified_gmt":"2022-10-27T12:21:26","slug":"ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/","title":{"rendered":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>&#8211; Conference call scheduled for <span class=\"xn-chron\">4:30 p.m. Eastern Time<\/span><\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">WALTHAM, Mass.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 27, 2022<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that it will hold a conference call on <span class=\"xn-chron\">Thursday, November 3, 2022<\/span>, at <span class=\"xn-chron\">4:30 p.m. Eastern Time<\/span> to review third quarter 2022 financial results and provide a business overview.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg\" title=\"Ardelyx logo (PRNewsFoto\/Ardelyx) (PRNewsfoto\/Ardelyx)\" alt=\"Ardelyx logo (PRNewsFoto\/Ardelyx) (PRNewsfoto\/Ardelyx)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>To participate in the conference call, please dial (866) 374-5140 (domestic) or (404) 400-0571 (international) and enter the pin 79680409#. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company&#8217;s website at\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3690498-1&amp;h=67116320&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2567583-1%26h%3D1439678458%26u%3Dhttp%253A%252F%252Fwww.ardelyx.com%252F%26a%3Dwww.ardelyx.com&amp;a=www.ardelyx.com\" target=\"_blank\" rel=\"nofollow noopener\">www.ardelyx.com<\/a>.\u00a0The webcast will be archived and available for replay for 30 days following the call.<\/p>\n<div class=\"wcag-arialevel-3\" style=\"font-size: 1.17em;font-weight: bold\" role=\"heading\">\n        <b>About Ardelyx, Inc.<\/b>\n      <\/div>\n<p>Ardelyx was founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx&#8217;s first approved product, IBSRELA<sup>\u00ae<\/sup> (tenapanor) is available in <span class=\"xn-location\">the United States<\/span> and <span class=\"xn-location\">Canada<\/span>. Ardelyx is developing XPHOZAH<sup>\u00ae<\/sup> (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed three successful Phase 3 trials. Ardelyx has a Phase 2 potassium lowering compound, RDX013, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and\/or heart disease and an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. Ardelyx has established agreements with Kyowa Kirin in <span class=\"xn-location\">Japan<\/span>, Fosun Pharma in <span class=\"xn-location\">China<\/span> and Knight Therapeutics in <span class=\"xn-location\">Canada<\/span> for the development and commercialization of tenapanor in their respective territories.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF16562&amp;sd=2022-10-27\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022-301660882.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022-301660882.html<\/a><\/p>\n<p>SOURCE  Ardelyx<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF16562&amp;Transmission_Id=202210270800PR_NEWS_USPR_____SF16562&amp;DateId=20221027\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire &#8211; Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass. , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that it will hold a conference call on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time to review third quarter 2022 financial results and provide a business overview. To participate in the conference call, please dial (866) 374-5140 (domestic) or (404) 400-0571 (international) and enter the pin 79680409#. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company&#8217;s website at\u00a0www.ardelyx.com.\u00a0The webcast will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-701830","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire &#8211; Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass. , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that it will hold a conference call on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time to review third quarter 2022 financial results and provide a business overview. To participate in the conference call, please dial (866) 374-5140 (domestic) or (404) 400-0571 (international) and enter the pin 79680409#. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company&#8217;s website at\u00a0www.ardelyx.com.\u00a0The webcast will be &hellip; Continue reading &quot;Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T12:21:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022\",\"datePublished\":\"2022-10-27T12:21:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1309911\\\/Ardelyx_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/\",\"name\":\"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1309911\\\/Ardelyx_Logo.jpg\",\"datePublished\":\"2022-10-27T12:21:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1309911\\\/Ardelyx_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1309911\\\/Ardelyx_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/","og_locale":"en_US","og_type":"article","og_title":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk","og_description":"PR Newswire &#8211; Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass. , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that it will hold a conference call on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time to review third quarter 2022 financial results and provide a business overview. To participate in the conference call, please dial (866) 374-5140 (domestic) or (404) 400-0571 (international) and enter the pin 79680409#. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company&#8217;s website at\u00a0www.ardelyx.com.\u00a0The webcast will be &hellip; Continue reading \"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-27T12:21:26+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022","datePublished":"2022-10-27T12:21:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/","name":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg","datePublished":"2022-10-27T12:21:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1309911\/Ardelyx_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2022-financial-results-on-november-3-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=701830"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701830\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=701830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=701830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=701830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}